Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst – ResMed (NYSE:RMD)

On Thursday, ResMed Inc RMD reported first-quarter adjusted EPS of $2.20, up 34% year over year, beating the consensus of $2.04. The company reported sales of $1.224 billion, up 11%,…

Continue ReadingSleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst – ResMed (NYSE:RMD)

Philip Morris’ Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands – Philip Morris Intl (NYSE:PM)

Stifel analyst Matthew E. Smith reiterated a Buy rating on Philip Morris International Inc PM, raising the price forecast to $145 from $138. Yesterday, the Marlboro maker reported third-quarter revenue…

Continue ReadingPhilip Morris’ Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands – Philip Morris Intl (NYSE:PM)

Ulta Beauty Faces ‘Transitional’ FY25, May Fall Short Of Long-Term Targets: Analyst – Ulta Beauty (NASDAQ:ULTA)

BofA Securities analyst Lorraine Hutchinson reiterated the Neutral rating on Ulta Beauty, Inc. ULTA with a price objective of $380. The analyst reduced the FY25 EPS estimate by 8% to…

Continue ReadingUlta Beauty Faces ‘Transitional’ FY25, May Fall Short Of Long-Term Targets: Analyst – Ulta Beauty (NASDAQ:ULTA)